Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
Glenn Polyak thought he was out of options when his Stage 4 melanoma spread to his brain, until he became only the second ...
4don MSN
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
Woman's World on MSN
New pancreatic cancer drug study offers major hope for treatment
In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But ...
A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
Cancer is frightening enough to make us rush straight into treatment, often without a second thought, and understandably so.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results